Hospital News and Research

RSS

New research could improve how brain cancer and tumors are treated

Australian researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against tumors, while reducing damage to healthy tissue.

29 Aug 2026

Updated consensus offers new roadmap for childhood bedwetting care

Nocturnal enuresis (NE) in school-age children is more than a nighttime inconvenience: when persistent, it can affect self-esteem, sleep, family life and social functioning.

28 Aug 2026

Digital technologies reshape clinical research and public health

JMIR Publications this week released seven feature News and Perspectives articles covering how digital tools are transforming clinical research, public health readiness, health care institutions, and consumer choices.

28 Aug 2026

Machine learning maps changing immune response over time in sepsis

Researchers have mapped how the immune response in people with sepsis changes over time.

28 Aug 2026

Newly developed radiotheranostic pair identifies and treats renal tumors

A newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC).

28 Aug 2026

New research questions decades-old assumptions about brain cancer treatment

Australian researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against tumors, while reducing damage to healthy tissue.

28 Aug 2026

POET-II trial reduces antibiotic duration for infective endocarditis by two weeks

A response-tailored strategy reduced antibiotic duration by two weeks without compromising the safety of patients with left-sided infective endocarditis.

28 Aug 2026

New guidelines simplify heart failure phenotypes into two groups

Reflecting improved understanding and treatment advances, new European Society of Cardiology (ESC) Guidelines on heart failure have been published online today in the European Heart Journal and will be presented at ESC Congress 2026 this afternoon.

28 Aug 2026

New international guidelines highlight the extensive benefits of cardiac rehabilitation

The European Society of Cardiology (ESC) Guidelines on cardiac rehabilitation have been published online today in the European Heart Journal.

28 Aug 2026

Blood-brain barrier-crossing blood pressure drugs linked to lower dementia risk

In a large Australian cohort of adults with hypertension, use of blood-brain barrier-crossing antihypertensive medications was associated with a lower risk of dementia and mortality than use of non-crossing drugs. The association was strongest for beta-blockers and angiotensin II receptor blockers, although the observational design means the findings cannot establish causality.

27 Aug 2026

Parkinson’s disease imposes €22.8 billion economic burden across Europe

The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion at 2025 prices, a new study published today in Movement Disorders has shown.

27 Aug 2026

Newly identified cells protect lung tumors from immune attacks

Researchers at Columbia University have discovered a new type of cell that protects lung cancers from attacks by the immune system.

27 Aug 2026

Early rasburicase treatment linked to better outcomes in tumor lysis syndrome

Tumor lysis syndrome (TLS) is a life-threatening emergency that occurs when large numbers of cancer cells break down rapidly, releasing substances such as uric acid into the bloodstream that can damage the kidneys and cause serious complications.

27 Aug 2026

Poison control calls could prevent many unnecessary pediatric ER visits

About 65% of young children brought to New Jersey emergency departments for suspected poisoning probably didn't need emergency care and could have stayed home if their families had called poison control before rushing to the hospital, according to Rutgers researchers.

27 Aug 2026

Study reveals how SGLT2 inhibitors improve failing heart function

Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely used for heart failure, work by activating a key enzyme that helps heart cells produce and use energy more efficiently.

27 Aug 2026

$New AI tool predicts hip fracture risk years ahead$

New AI tool predicts hip fracture risk years ahead

Preventing hip fractures depends on identifying people at high risk early. Researchers at the University of Gothenburg have now developed a new clinical decision support tool that makes this possible-without requiring clinic visits or patient questionnaires.

27 Aug 2026

Researchers tested dozens of clues for long COVID. One finding stood out

A nationwide study of 218 people in the Faroe Islands examined clinical, neurological, and blood-based markers associated with persistent symptoms around six months after SARS-CoV-2 infection. Despite extensive testing, researchers found no convincing biomarker for long COVID, while a statistical association with lower INR remained within the normal clinical range and requires replication.

27 Aug 2026

Ketogenic diet excels at reversing prediabetes and fatty liver

There is no shortage of popular diets to try, and they can generally produce weight loss if followed to the letter. But are all diet plans created equal in terms of reducing the cardiometabolic risks that come with obesity, such as Type 2 diabetes and liver disease?

27 Aug 2026

Ketogenic diet provides greatest health benefits for treating obesity

A diet that severely limits carbohydrates but is high in fat has the greatest health benefits for people with obesity compared to a Mediterranean diet or a low-fat diet, according to a clinical trial publishing August 27 in the Cell Press journal Cell Metabolism.

27 Aug 2026

Optimized EAP regimen delivers outstanding mobilization effects in multiple myeloma and lymphoma patients

This prospective, multicenter phase II study was conducted across 12 medical institutions in China and registered at ClinicalTrials.gov (NCT05536154).

27 Aug 2026